高级检索

    可乐定缓释片治疗注意缺陷多动障碍共患抽动障碍患儿疗效观察

    Efficacy of clonidine extended-release tablets in the treatment of children with attention deficit hyperactivity disorder comorbid with tic disorder

    • 摘要: 目的 评估可乐定缓释片治疗注意缺陷多动障碍(ADHD)共患抽动障碍患儿的疗效及其对神经免疫功能的影响。方法 收集2024年1月—12月在徐州医科大学附属医院儿科门诊或住院的ADHD共患抽动障碍患儿120例,随机分为可乐定缓释片组(观察组)和盐酸哌甲酯缓释片组(对照组),每组60例。采用t检验、χ2检验和秩和检验分析2组间的临床疗效、Conners父母问卷量表、耶鲁综合抽动严重程度量表评分、外周血T淋巴细胞亚群水平、神经递质水平和不良事件。结果 与对照组相比,观察组的总有效率更高(P<0.05)。观察组的品行问题、学习问题、心身障碍、多动-冲动、焦虑指数和多动指数得分较低(P<0.05),且获得更低的运动抽动评分、声音抽动评分和总分(P<0.05)。与治疗前相比,治疗后2组总T淋巴细胞、辅助T淋巴细胞、Th/Ts均升高,抑制T淋巴细胞降低,但观察组更为显著(P<0.05)。2组外周血5-羟色胺(5-HT)、去甲肾上腺素(NE)、多巴胺(DA)含量均较治疗前下降,观察组下降更为显著(P<0.05)。结论 可乐定缓释片可有效减少ADHD共患抽动障碍患儿注意缺陷和多动/冲动等,缓解抽动症状,其机制可能与免疫功能调节、神经递质紊乱改善有关。

       

      Abstract: Objective To evaluate the efficacy of clonidine extended-release tablets in the treatment of children with attention deficit hyperactivity disorder (ADHD) comorbid with tic disorder and to assess their effects on neuroimmune function. Methods A total of 120 children with ADHD comorbid with tic disorder, who were admitted to the Affiliated Hospital of Xuzhou Medical University from January 2024 to December 2024, were enrolled. They were randomly divided into two groups (n=60): a clonidine extended-release group (observation group) and a methylphenidate hydrochloride extended-release group (control group). The clinical efficacy, Conners' Parent Rating Scale (CPRS) scores, Yale Global Tic Severity Scale (YGTSS) scores, peripheral blood T lymphocyte subsets, neurotransmitter levels, and adverse events were analyzed by the t-test, chi-square test, and rank-sum test. Results The total effective rate in the observation group was significantly higher than that in the control group (P<0.05). The observation group showed significantly lower scores in conduct problems, learning problems, psychosomatic disorders, hyperactivity-impulsivity, anxiety index, and hyperactivity index (P<0.05). Moreover, their motor tic score, vocal tic score, and total YGTSS score were also significantly lower in the observation group (P<0.05). After treatment, both groups exhibited increases in total T lymphocytes, helper T lymphocytes, and Th/Ts ratios, and decreases in suppressor T lymphocytes compared with those before treatment; these changes were more pronounced in the observation group (P<0.05). The levels of peripheral blood serotonin (5-HT), norepinephrine (NE), and dopamine (DA) decreased in both groups after treatment, with a more significant reduction in the observation group (P<0.05). Conclusions Clonidine extended-release tablets effectively alleviate attention deficits, hyperactivity/impulsivity, and tic symptoms in children with ADHD comorbid with tic disorder. The therapeutic mechanism may be related to modulation of immune function and improvement of neurotransmitter imbalance.

       

    /

    返回文章
    返回